How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease—decision analysis and comparison of three international patient populations

BACKGROUND: We recently developed a clinical decision support tool, capable of estimating the likelihood of survival at 3 and 12 months following surgery for patients with operable skeletal metastases. After making it publicly available on www.PATHFx.org, we attempted to externally validate it using...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Piccioli, Andrea, Spinelli, M. Silvia, Forsberg, Jonathan A., Wedin, Rikard, Healey, John H., Ippolito, Vincenzo, Daolio, Primo Andrea, Ruggieri, Pietro, Maccauro, Giulio, Gasbarrini, Alessandro, Biagini, Roberto, Piana, Raimondo, Fazioli, Flavio, Luzzati, Alessandro, Di Martino, Alberto, Nicolosi, Francesco, Camnasio, Francesco, Rosa, Michele Attilio, Campanacci, Domenico Andrea, Denaro, Vincenzo, Capanna, Rodolfo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4443666/
https://ncbi.nlm.nih.gov/pubmed/25998535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1396-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados